Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: It is controversial whether iRECIST has a significant impact over RECIST 1.1 in evaluating the efficacy of immune checkpoint inhibitor treatment. We aimed to evaluate the impact of iRECIST on assessing treatment efficacy of immune checkpoint inhibitors over RECIST 1.1 through a syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyo Jung, Kim, Gun Ha, Kim, Kyung Won, Lee, Choong Wook, Yoon, Shinkyo, Chae, Young Kwang, Tirumani, Sree Harsha, Ramaiya, Nikhil H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795764/
https://www.ncbi.nlm.nih.gov/pubmed/33561078
http://dx.doi.org/10.3390/cancers13010120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795764/
https://www.ncbi.nlm.nih.gov/pubmed/33561078
http://dx.doi.org/10.3390/cancers13010120

Ejemplares similares